Description of Research Expertise:
Psoriatic Arthritis, Epidemiology, Pharmacoepidemiology
Selected Publications:
Mease Philip J, Gladman Dafna D, Ogdie Alexis, Coates Laura C, Behrens Frank, Kavanaugh Arthur, Mcinnes Iain, Queiro Rubén, Guerette Benoit, Brunori Michele, Teng Lichen, Smolen Josef S: Treatment to Target in Psoriatic Arthritis with Apremilast: Probability of Achieving Targets and Comprehensive Control of Disease Manifestations. Arthritis care & research : 2020.
Orbai Ana-Maria, Ogdie Alexis, Gossec Laure, Tillett William, Leung Ying Ying, Gao Jingjing, Trivedi Mona, Tasset Chantal, Meuleners Luc, Besuyen Robin, Hendrikx Thijs, Coates Laura C: Effect of filgotinib on health-related quality of life in active psoriatic arthritis: a randomized phase 2 trial (EQUATOR). Rheumatology (Oxford, England) : 2019.
Walsh Jessica A, Wan Marilyn T, Willinger Christine, Husni M Elaine, Scher Jose U, Reddy Soumya M, Ogdie Alexis: Measuring outcomes in psoriatic arthritis: comparing Routine Assessment of Patient Index Data (RAPID3) and Psoriatic Arthritis Impact of Disease (PSAID). The Journal of rheumatology : 2019.
Hwang Mark C, Ogdie Alexis, Puravath Abin, Reveille John D: Reliability and Validity of Patient-Reported Outcomes Measurement Information System Short Forms in Ankylosing Spondylitis. The Journal of rheumatology : 2019.
Lee Moa P, Desai Rishi J, Jin Yinzhu, Brill Gregory, Ogdie Alexis, Kim Seoyoung C: Association of Ustekinumab vs TNF Inhibitor Therapy With Risk of Atrial Fibrillation and Cardiovascular Events in Patients With Psoriasis or Psoriatic Arthritis. JAMA dermatology 155 (6): 700-707,2019.
Ogdie Alexis, Benjamin Nowell W, Reynolds Regan, Gavigan Kelly, Venkatachalam Shilpa, de la Cruz Marie, Flood Emuella, Schwartz Ethan J, Romero Beverly, Park Yujin: Real-World Patient Experience on the Path to Diagnosis of Ankylosing Spondylitis. Rheumatology and therapy 6 (2): 255-267,2019.
Singh P, Forman H, Adamson AS, Mostaghimi A, Ogdie AR, Oganisian A, Barbieri JS: Impact of Industry Payments on Prescribing Patterns for Tumor Necrosis Factor Inhibitors Among Medicare Beneficiaries. Journal of General Internal Medicine 34 (2): 176-178,2019.
Duarte-García A, Leung YY, Coates LC, Beaton D, Christensen R, Craig E, de Wit M, Eder L, Fallon L, FitzGerald O, Gladman DD, Goel N, Holland R, Lindsay C, Maxwell L, Mease P, Orbai AM, Shea B, Strand V, Veale DJ, Tillett W*, Ogdie A*: Endorsement of the 66/68 joint count for the measurement of musculoskeletal disease activity: OMERACT 2018 Psoriatic Arthritis workshop report. Journal of Rheumatology 46 (8): 996-1005,2019.
Basiaga ML, Ross ME, Gerber JS, Ogdie A: Incidence of Pneumocystis jirovecii and Adverse Events Associated With Pneumocystis Prophylaxis in Children Receiving Glucocorticoids. Journal of the Pediatric Infectious Diseases Society
7 (4): 283-289,2018.
Perez-Chada LM, Cohen JM, Gottlieb AB, Duffin KC, Garg A, Latella J, Armstrong AW, Ogdie A, Merola JF: Achieving international consensus on the assessment of psoriatic arthritis in psoriasis clinical trials: an International Dermatology Outcome Measures (IDEOM) initiative. Arch Dermatol Res
310 (9): 701-710,2018.